References
- Fermé C, Eghbali H, Meerwaldt JH, et al.; EORTC-GELA H8 Trial. Chemotherapy plus involved field radiation in early stage Hodgkin's disease. N Engl J Med 2007;357:1916–1927.
- Guermazi A, Brice P, de Kerviler EE, et al. Extra nodal Hodgkin disease: spectrum of disease. RadioGraphics 2001;21:161–169.
- Ponzoni M, Fumagalli L, Rossi G, et al. Isolated bone marrow manifestation of HIV associated Hodgkin lymphoma. Mod Pathol 2002;15:1273–1278.
- Ponzoni M, Ciceri F, Crocchiolo R, et al. Isolated bone marrow occurrence of classic hodgkin's lymphoma in an HIV negative patient. Haematologica 2006;91:8–9.
- Skinnider BF, Mak TW. The role of cytokines in classical hodgkin lymphoma. Blood 2002;99:4283–4297.
- Kurzrock R, Redman J, Cabanillas F, et al. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res 1993;53:2118–2122.
- Benharroch D, Prinsloo I, Apte RN, et al. Interleukin 1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlations with clinical and morphological inflammatory features. Eur Cytokine Netw 1996;7:51–57.
- Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 2005;106:2444–2451.
- Kanakry JA, Li H, Gellert LL, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood 2013;121:3547–3553.
- Rassidakis GZ, Medeiros LJ, Viviani S, et al. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. J Clin Oncol 2002;20:1278–1282.
- Tzankov A, Krugmann J, Fend F, et al. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases. Clin Cancer Res 2003;9:1381–1386.
- Bai MC, Jiwa NM, Horstman A, et al. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. J Pathol 1994;174:49–55.
- Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. pp 323–325.